Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
Moodys
Express Scripts
Johnson and Johnson
Medtronic
Dow

Last Updated: October 23, 2019

DrugPatentWatch Database Preview

Hisun Pharm Hangzhou Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for HISUN PHARM HANGZHOU, and what generic and branded alternatives to HISUN PHARM HANGZHOU drugs are available?

HISUN PHARM HANGZHOU has sixteen approved drugs.



Summary for Hisun Pharm Hangzhou
US Patents:0
Tradenames:14
Ingredients:14
NDAs:16

Drugs and US Patents for Hisun Pharm Hangzhou

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hisun Pharm Hangzhou PRAVASTATIN SODIUM pravastatin sodium TABLET;ORAL 206061-002 Nov 23, 2018 AB RX No No   Start Trial   Start Trial
Hisun Pharm Hangzhou SIMVASTATIN simvastatin TABLET;ORAL 206557-002 Nov 13, 2017 DISCN No No   Start Trial   Start Trial
Hisun Pharm Hangzhou EPIRUBICIN HYDROCHLORIDE epirubicin hydrochloride INJECTABLE;INJECTION 090075-002 Mar 25, 2010 AP RX No No   Start Trial   Start Trial
Hisun Pharm Hangzhou DAUNORUBICIN HYDROCHLORIDE daunorubicin hydrochloride INJECTABLE;INJECTION 208759-001 Apr 12, 2019 AP RX No No   Start Trial   Start Trial
Hisun Pharm Hangzhou PRAVASTATIN SODIUM pravastatin sodium TABLET;ORAL 206061-001 Nov 23, 2018 AB RX No No   Start Trial   Start Trial
Hisun Pharm Hangzhou TICAGRELOR ticagrelor TABLET;ORAL 208575-001 Jan 23, 2019 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Boehringer Ingelheim
Mallinckrodt
Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.